Scholar Rock Banner Image

Scholar Rock

  • Ticker SRRK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Scholar Rock Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of seriousMore diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock’s newly elucidated understanding of the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path.
4.8 / 5.0 (118)

Scholar Rock reports have an aggregate usefulness score of 4.8 based on 118 reviews.

Scholar Rock

Most Recent Annual Report

Scholar Rock
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Scholar Rock Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!